The CEBM Oxford COVID-19 Evidence Service continues its excellent work, providing regularly updated rapid reviews relating to the Coronavirus pandemic.
With over 10 million page views globally, the Evidence Service is now recognised as having ‘a lasting research value’ by the Oxford University Bodleian Library and worthy of permanent preservation in their web archive.
So far, 76 reviews have been added in April alone, providing background evidence to support clinicians on the front line make informed decisions on the fundamental practices of COVID-19 care within their field of expertise.
Authors and contributors include but are by no means limited to:
Jason Oke, senior statistician at the Nuffield Department of Primary Care Health Sciences
Carl Heneghan, Professor of Evidence-Based Medicine, Director of the Centre for Evidence-Based Medicine
Tom Jefferson, senior associate tutor and honorary research fellow, Centre for Evidence-Based Medicine
Trish Greenhalgh, Professor of Primary Care Health Sciences
Oxford COVID-19 Evidence Service
Centre for Evidence-Based Medicine
Nuffield Department of Primary Care Health Sciences
British Islamic Medical Association
County Durham and Darlington NHS Foundation Trust
Translational and Clinical Research Institute, Newcastle University
Newcastle upon Tyne NHS Hospitals Foundation Trust
Tsinghua University School of Medicine
Hampshire Hospitals NHS Foundation Trust
To date, the most viewed reviews are:
Chloroquine and hydroxychloroquine: Current evidence for their effectiveness in treating COVID-19
Each study disseminates research by showcasing the importance of evidence in determining the final verdict. The value of these rapid reviews is further represented below:
The UK Government's Cabinet Office has requested advice on association versus causation when reporting deaths in hospitals only versus in the community and/or care homes
Content is distributed to 660 journalists daily via the Science Media Centre
Since April 1st, 2020, over one million new users have visited CEBM.net
Read more at CEBM.net